Microbix Biosystems Inc. Company Review & Valuation MBXBF
About Microbix Biosystems Inc.
Microbix Biosystems Inc. develops and commercializes biological and technology solutions for human health and wellbeing in North America, Europe, and internationally. It offers infectious disease antigens, including viral, bacterial, and parasitic products, which are used in various applications, such as immunodiagnostic assays comprising ELISA, chemiluminescent automated immunoassays, immunohistochemistry, immunofluorescence, latex agglutination, rapid tests, and flow cytometry; controls for diagnostic assays; basic and applied research in virology, microbiology, cell biology, immunology, and pathology; and for vaccine and antiviral research and development. The company also provides quality assessment products, including PROCEEDx Verification/Validation samples, which are research use only products for use in test system IQ/OQ/PQ, verification/validation, and training; PTDx proficiency testing products; and REDx Controls, which are designed to enhance the diagnostic quality outcome by early detection of the deviations from desired assay performance. Its development pipeline includes Kinlytic Urokinase for injection, a thrombolytic biologic drug used to treat blood clots; and LumiSort cell-sorting, a technology for sorting of somatic cells that could be used to enrich cell populations of interest, such as in sexing semen. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
- Mississauga, Canada
Primary Stock Exchange Listings